These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25840949)

  • 1. Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.
    Rawat P; Manglani K; Gupta S; Kalam A; Vohora D; Ahmad FJ; Talegaonkar S
    Pharm Res; 2015 Oct; 32(10):3149-58. PubMed ID: 25840949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting bone targeting potential of novel hydroxyapatite based surface modified PLGA nanoparticles of risedronate: Pharmacokinetic and biochemical assessment.
    Rawat P; Ahmad I; Thomas SC; Pandey S; Vohora D; Gupta S; Ahmad FJ; Talegaonkar S
    Int J Pharm; 2016 Jun; 506(1-2):253-61. PubMed ID: 27113864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of surface-modified poly(D,L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone.
    Choi SW; Kim JH
    J Control Release; 2007 Sep; 122(1):24-30. PubMed ID: 17628158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
    Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
    Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate-decorated biodegradable polymeric micelles for potential bone-targeted delivery of vancomycin.
    Cong Y; Quan C; Liu M; Liu J; Huang G; Tong G; Yin Y; Zhang C; Jiang Q
    J Biomater Sci Polym Ed; 2015; 26(11):629-43. PubMed ID: 25994241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
    Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
    Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis.
    Fazil M; Hassan MQ; Baboota S; Ali J
    Drug Deliv; 2016 Sep; 23(7):2428-2438. PubMed ID: 25625496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
    Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
    Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risedronate/zinc-hydroxyapatite based nanomedicine for osteoporosis.
    Khajuria DK; Disha C; Vasireddi R; Razdan R; Mahapatra DR
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():78-87. PubMed ID: 27040198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
    Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation strategies for active targeting of PLA/PLGA nanoparticles.
    Betancourt T; Byrne JD; Sunaryo N; Crowder SW; Kadapakkam M; Patel S; Casciato S; Brannon-Peppas L
    J Biomed Mater Res A; 2009 Oct; 91(1):263-76. PubMed ID: 18980197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
    Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
    J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles.
    Avgoustakis K; Beletsi A; Panagi Z; Klepetsanis P; Livaniou E; Evangelatos G; Ithakissios DS
    Int J Pharm; 2003 Jun; 259(1-2):115-27. PubMed ID: 12787641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of DHAQ-loaded mPEG-PLGA-mPEG nanoparticles and evaluation of drug release behaviors in vitro/in vivo.
    Duan Y; Sun X; Gong T; Wang Q; Zhang Z
    J Mater Sci Mater Med; 2006 Jun; 17(6):509-16. PubMed ID: 16691348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
    Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
    Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Osteoporosis Treatment through Targeted Nanoparticle Delivery of Risedronate: In Vivo Evaluation and Bioavailability Enhancement.
    Saifi Z; Shafi S; Ralli T; Jain S; Vohora D; Mir SR; Alhalmi A; Noman OM; Alahdab A; Amin S
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(lactide-co-glycolide)-methoxy-poly(ethylene glycol) nanoparticles: drug loading and release properties.
    Katsikogianni G; Avgoustakis K
    J Nanosci Nanotechnol; 2006; 6(9-10):3080-6. PubMed ID: 17048521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.